Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer

  1. Calvo, R.
  2. Jiménez, R.Ma.
  3. Trocóniz, I.F.
  4. Suárez, E.
  5. Gonzalo, A.
  6. Lucero, Ma.L.
  7. Raczka, E.
  8. Orjales, A.
Journal:
Cancer Chemotherapy and Pharmacology

ISSN: 0344-5704

Year of publication: 1998

Volume: 42

Issue: 5

Pages: 418-422

Type: Article

DOI: 10.1007/S002800050839 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus